NCT03481621

Brief Summary

Vulvodynia is a common condition in women (16%); however, at this time there is no known effective non-pharmacological therapy reported. Acupuncture is one complementary and alternative medicine therapy used by many patients with vulvodynia; some case reports show that acupuncture may be an effective intervention. In recent years, there were some studies registered took at like at actual trials of acupuncture on vulvodynia, but either they did not reach the trial aims, some studies did not get enough patients or the trial designs mimic drug studies and did not reflect acupuncture real characteristics. This study evaluates acupuncture for the treatment of vulvodynia; specifically, if it reduces vulvar pain, pain duration and pain with intercourse. It also examines how long the effect of acupuncture lasts in women with vulvodynia. One third of the women will receive acupuncture focused on pudendal nerve distribution area; another one third of the women will receive acupuncture focused on traditional meridian points; the other one third of women will use standard care (without acupuncture). Women who get a reduction in pain (included in subjective and objective scores) will have their pain monitored once a week for up to 6 weeks to see if the acupuncture effect lasts.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 8, 2018

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 29, 2018

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

September 3, 2020

Status Verified

September 1, 2020

Enrollment Period

3 years

First QC Date

March 8, 2018

Last Update Submit

September 1, 2020

Conditions

Keywords

Vulvodynia

Outcome Measures

Primary Outcomes (1)

  • Pain Score (objective)

    Figure out the pain score using Visual Analog pain scale(VAS) using cotton swab , \[score 0-no pain, 10-strongest (unbearable) pain\]. Expected clinical significant difference (ECSD): 3.

    at the end of 6 weeks

Secondary Outcomes (3)

  • Pain Score (Subjective)

    at the end of 6 weeks

  • Pain duration

    at the end of 6 weeks

  • Intercourse pain

    at the end of 6 weeks

Study Arms (3)

Group1a, Acupuncture on Vulvodynia

ACTIVE COMPARATOR

Focus on using the local points in pudendal nerve distribution area

Device: Acupuncture

Group1b, Acupuncture on Vulvodynia

ACTIVE COMPARATOR

Focus on traditional acupuncture using common meridian or distal points

Device: Acupuncture

Group2, Standard care or waiting lists

ACTIVE COMPARATOR

Standard care without acupuncture

Other: Standard care

Interventions

Needle size: #32(0.22 mm), 1-1.5 inch(30-40 mm long); Acupuncture time and frequency: 45 min per session, once or twice per week, for 6-12 sessions total (in 6 weeks).

Also known as: Needling
Group1a, Acupuncture on VulvodyniaGroup1b, Acupuncture on Vulvodynia

PT, pain medications, nerve block, etc

Also known as: Routine treatments
Group2, Standard care or waiting lists

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • diagnosis of generalized vulvodynia or provoked vestibulodynia by OB/GYN doctor(s) or pain specialist(s); 18 to 45 years old.
  • Current pain score 4 or higher with tampon insertion and removal performed, or cotton swab test, at the initial screening exam
  • speak and read English or Chinese.

You may not qualify if:

  • infectious conditions of the vulvar/vagina;
  • inflammatory conditions of the vulvar/vagina;
  • neoplastic disorders of the vulvar/vagina;
  • neurologic disorders of the vulvar/vagina;
  • acute trauma to the genitals;
  • iatrogenic conditions of the genitals
  • hormonal deficiencies
  • co-morbid pelvic pain conditions (to avoid confounding pain outcomes) such as pelvic inflammatory disease and documented history of endometriosis
  • menopause
  • patients have active migraine headaches, temporomandibular joint disease (TMJ), irritable bowel syndrome (IBS), interstitial cystitis, painful bladder syndrome, or fibromyalgia, in past 6 month.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McLean Center for Complementary and Alternative Medicine,PLC

Vienna, Virginia, 22182, United States

RECRUITING

Related Publications (1)

  • Fan AY, Alemi SF, Zhu YH, Rahimi S, Wei H, Tian H, He D, Gong C, Yang G, He C, Ouyang H. Effectiveness of two different acupuncture strategies in patients with vulvodynia: Study protocol for a pilot pragmatic controlled trial. J Integr Med. 2018 Nov;16(6):384-389. doi: 10.1016/j.joim.2018.10.004. Epub 2018 Oct 10.

MeSH Terms

Conditions

VulvodyniaVulvar Vestibulitis

Interventions

Acupuncture TherapyStandard of Care

Condition Hierarchy (Ancestors)

Vulvar DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesVulvitis

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Arthur Y Fan, MD(CHN),PhD

    McLean Center for Complementary and Alternative Medicine, PLC

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Arthur Y Fan, MD(CHN),PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
All participants will get real treatments, the first group patients will get acupuncture treatments focus on the points within pudendal nerve distribution area; the second group patients will get acupuncture treatments focus on the points from traditional meridian theory. And the third group will get the standard care (no acupuncture). Participants and outcomes assessor will be blinded for the study aims.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Acupuncture 1: focus on the points within pudendal nerve distribution arae; Acupuncture 2: focus on the points from traditional meridian theory; Standard care: no acupuncture, but use physical therapy, pain medications, nerve blocking, etc.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director,Principal Investigator

Study Record Dates

First Submitted

March 8, 2018

First Posted

March 29, 2018

Study Start

January 1, 2018

Primary Completion

December 31, 2020

Study Completion

December 31, 2021

Last Updated

September 3, 2020

Record last verified: 2020-09

Locations